Structural modification patterns from agonists to antagonists and their application to drug design--a new serotonin (5-HT3) antagonist series.
Structural variations from agonists to their selective antagonists seemed to follow certain patterns. To analyze the variation patterns in the structural modification processes in past examples as well as to utilize the "common" variation patterns as possible principles to design new selective antagonistic drugs, the structures of agonists and their antagonists were superimposed on a two-dimensional grid template composed of regular hexagons and the topological similarities and dissimilarities of substructural elements between agonists and antagonists were examined. Between several pairs of neurotransmitter amines and their "selective" antagonists, similar patterns were disclosed in their structural modification processes. The generalized structural modification patterns were successfully applied as guiding principles to design and identify a new prototype structure of the 5-HT3 antagonist. The prototype structure was optimized by use of QSAR procedures leading to a compound which shows a potent antiemetic activity as well as a powerful gastrointestinal-motility modulation.
Ohtaka
H
H
New Drug Research Laboratories, Kanebo Ltd., Osaka, Japan.
Fujita
T
T
D000818:Animals; D015195:Drug Design; D006801:Humans; D017981:Receptors, Neurotransmitter / Q000187:drug effects*; D012702:Serotonin Antagonists / Q000737:chemistry* / Q000494:pharmacology; D013329:Structure-Activity Relationship
D017981:Receptors, Neurotransmitter; D012702:Serotonin Antagonists